Monitor for any takedown or prospectus supplement under these shelves. If the company announces a secondary offering or at-the-market program, expect significant dilution pressure. The multiple effective shelves increase the likelihood of a capital raise in the near to medium term.
Price Chart
Executive Summary
Esperion Therapeutics had four shelf registration statements (File Nos. 333-286631, 333-264303, 333-258396, 333-208701) declared effective by the SEC on July 15, 2026. This gives the company the ability to issue and sell securities at any time, creating a meaningful dilution overhang. The batch of four simultaneous effectiveness notices amplifies the potential for future capital raises, which is a bearish signal given the company's $819M market cap and predominantly hold/sell analyst consensus.
Key Facts
- Four separate shelf registration statements became effective on July 15, 2026.
- File numbers: 333-286631, 333-264303, 333-258396, 333-208701.
- Esperion can now offer and sell securities under these shelves at any time.
- Market cap is approximately $819M with 0% analyst bullish rating.
- Top institutional holder Wasatch Advisors holds $6M and recently showed a near-exit move.
Financial Impact
Potential future dilution from securities offerings under four active shelves; no specific offering size disclosed.
Risk Factors
- Dilutive secondary offering or convertible issuance could materially reduce per-share value.
- Stock overhang may suppress price appreciation until the company clarifies its capital needs.
- Analyst consensus is already bearish, and additional supply could exacerbate selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (ESPR) — Batch item 1 | 9999999995-26-002307 |
| Document: 9999999995-26-002307-index.html | 9999999995-26-002305 |
| Document: 9999999995-26-002307.txt | 9999999995-26-002304 |
| EFFECT Filing (ESPR) — Batch item 4 | 9999999995-26-002305 |
| Document: 9999999995-26-002305-index.html | 9999999995-26-002307 |
| Document: 9999999995-26-002305.txt | 9999999995-26-002307 |
| EFFECT Filing (ESPR) — Batch item 7 | 9999999995-26-002304 |
| Document: 9999999995-26-002304-index.html | 9999999995-26-002307 |
| Document: 9999999995-26-002304.txt | 9999999995-26-002307 |
| EFFECT Filing (ESPR) — Batch item 10 | 9999999995-26-002303 |
| Document: 9999999995-26-002303-index.html | 9999999995-26-002307 |
| Document: 9999999995-26-002303.txt | 9999999995-26-002307 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Court Ruling | — | awaiting T+5 | — | — |
Aug 13, 2026 7w ago | Institutional Cluster | — | awaiting T+5 | — | — |
Jul 23, 2026 10w ago | 15-12G | — | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 25-NSE | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 8-K | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jun 16, 2026 15w ago | DEFA14A | $3.17 $3.15 | ▼ −0.63% | ▲ +0.41% | — |
Jun 11, 2026 16w ago | Institutional Cluster | $3.15 $3.17 | ▲ +0.63% | ▲ +0.20% | — |
Jun 9, 2026 16w ago | 8-K | $3.14 $3.16 | ▲ +0.64% | ▼ −2.80% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access